{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:39:23Z","timestamp":1783539563583,"version":"3.55.0"},"reference-count":36,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: Latent tuberculosis (LTB) is a condition where the patient is infected with Mycobacterium tuberculosis but does not develop active TB. There\u2019s a possibility of tuberculosis (TB) activation following the introduction of anti-TNFs.  Objective: To assess the risk of biological therapy inducing LTB during inflammatory bowel diseases (IBD) treatment over 15 years in a high-risk area in Brazil.  Methods: A retrospective study of an IBD patients\u2019 database was carried out in a private reference clinic in Brazil. All patients underwent TST testing and chest X-ray prior to treatment, and once a year after starting it. Patients were classified according to the Montreal stratification and risk factors were considered for developing TB.  Results: Among the analyzed factors, age and gender were risk factors for LTB. DC (B2 and P) and UC (E2) patients showed a higher number of LTB cases with statistical significance, what was also observed for adalimumab and infliximab users, compared to other medications, and time of exposure to them favored it significantly. Other factors such as enclosed working environment have been reported as risk.  Conclusion: The risk of biological therapy causing LTB is real, so patients with IBD should be continually monitored. This study reveals that the longer the exposure to anti-TNFs, the greater the risk.<\/jats:p>","DOI":"10.1590\/s0004-2803.24612023-148","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T18:12:06Z","timestamp":1710526326000},"source":"Crossref","is-referenced-by-count":4,"title":["RATE OF INFECTION (TUBERCULOSIS) IN BRAZILIANS IBD PRIVATE PATIENTS: FOLLOW-UP 15 YEARS"],"prefix":"10.1590","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7266-1471","authenticated-orcid":false,"given":"Didia B","family":"CURY","sequence":"first","affiliation":[{"name":"Cl\u00ednica Scope,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8573-4086","authenticated-orcid":false,"given":"Liana C B","family":"CURY","sequence":"additional","affiliation":[{"name":"Universidade Uniderp,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-6669","authenticated-orcid":false,"given":"Ana C","family":"MICHELETTI","sequence":"additional","affiliation":[{"name":"Universidade Federal de Mato Grosso do Sul,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0586-8226","authenticated-orcid":false,"given":"Rog\u00e9rio A","family":"OLIVEIRA","sequence":"additional","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8757-0731","authenticated-orcid":false,"given":"Jos\u00e9 J S","family":"GON\u00c7ALVES","sequence":"additional","affiliation":[{"name":"Universidade Uniderp,  Brasil; Universidade Federal de Mato Grosso do Sul,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","article-title":"The challenges to eliminating tuberculosis in Brazil","volume":"27","author":"Barreira D","year":"2018","journal-title":"Epidemiol Serv Saude"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1590\/0074-02760150235","article-title":"Incidence of active mycobacterial infections in Brazilian patients with chronic inflammatory arthritis and negative evaluation for latent tuberculosis infection at baseline - A longitudinal analysis after using TNF\u03b1 blockers","volume":"110","author":"Gomes CM","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref3","first-page":"1","article-title":"Evaluating strategies for control of tuberculosis in prisons and prevention of spillover into communities: An observational and modeling study from Brazil","volume":"16","author":"Mabud TS","year":"2019","journal-title":"PLoS Med"},{"key":"ref4","first-page":"629","article-title":"BCG vaccines for the prevention of tuberculosis in the world","volume":"72","author":"Hashimoto T","year":"1997","journal-title":"Kekkaku"},{"key":"ref5","first-page":"544","article-title":"Deaths attributed to multiple causes and involving tuberculosis in the state of Rio de Janeiro Brazil between 1999 and 2001","volume":"32","author":"Santo AH","year":"2006","journal-title":"J Bras Pneumol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.5217\/ir.2017.15.4.524","article-title":"Fatal infections in older patients with inflammatory bowel disease on anti-tumor necrosis factor therapy","volume":"15","author":"Lee WS","year":"2017","journal-title":"Intest Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1164\/rccm.2508001","article-title":"Controlling tuberculosis in the United States","volume":"172","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"ref8","first-page":"392","article-title":"Latent tuberculosis infection screening in juvenile idiopathic arthritis patients preceding anti-TNF therapy in a tuberculosis high-risk country","volume":"57","author":"Brunelli JB","year":"2017","journal-title":"Rev Bras Reumatol"},{"key":"ref9","first-page":"477","article-title":"Incidence of tuberculosis among patients with rheumatoid arthritis using TNF blockers in Brazil: data from the Brazilian Registry of Biological Therapies in Rheumatic Diseases (Registro Brasileiro de Monitora\u00e7\u00e3o de Terapias Biol\u00f3gicas - BiobadaBrasil)","volume":"57","author":"Yonekura CL","year":"2017","journal-title":"Rev Bras Reumatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/14740338.2019.1612872","article-title":"Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice","volume":"18","author":"Cantini F","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0184061","article-title":"Knowledge about tuberculosis transmission and prevention and perceptions of health service utilization among index cases and contacts in Brazil: Understanding losses in the latent tuberculosis cascade of care","volume":"12","author":"Salame FM","year":"2017","journal-title":"PLoS One"},{"key":"ref12","first-page":"87","article-title":"Importance of TB contact investigations","volume":"18","author":"Bartu V","year":"2016","journal-title":"Respir Med Case Rep"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.5217\/ir.2018.00023","article-title":"High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India","volume":"16","author":"Agarwal A","year":"2018","journal-title":"Intest Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/annrheumdis-2013-204960","article-title":"Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?","volume":"74","author":"Arkema EV","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2018.33.e292","article-title":"Incidence of active tuberculosis within one year after tumor necrosis factor inhibitor treatment according to latent tuberculosis infection status in patients with inflammatory bowel disease","volume":"33","author":"Kang J","year":"2018","journal-title":"J Korean Med Sci"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207400","article-title":"Tuberculosis among correctional facility workers: A systematic review and meta-analysis","volume":"13","author":"Grenzel ML","year":"2018","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.5588\/ijtld.17.0526","article-title":"Prevalence and screening of active tuberculosis in a prison in the South of Brazil","volume":"22","author":"Pelissari DM","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref18","article-title":"Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required","volume":"14","author":"Puga MAM","year":"2019","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/ecco-jcc\/jjx022","article-title":"Early tuberculin skin test for the diagnosis of latent tuberculosis infection in patients with inflammatory Bowel disease","volume":"11","author":"Taxonera C","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/14740338.2019.1577817","article-title":"Update upon the infection risk in patients receiving TNF alpha inhibitors","volume":"18","author":"Murdaca G","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.5588\/ijtld.15.0743","article-title":"Epidemiological study of hepatitis B virus among prisoners with active tuberculosis in Central Brazil","volume":"20","author":"Iglecias LM","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref22","series-title":"Guidelines for tuberculosis control in Brazil","year":"2011"},{"key":"ref23","first-page":"1018","article-title":"III Brazilian Thoracic Association Guidelines on tuberculosis","volume":"35","author":"Conde MB","year":"2009","journal-title":"J Bras Pneumol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5588\/ijtld.18.0201","article-title":"Effect of neonatal bacille Calmette-Gu\u00e9rin on the tuberculin skin test reaction in the first 2 years of life","volume":"23","author":"Kurtz T","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref25","first-page":"1401","article-title":"Age-specific cut-offs for the tuberculin skin test to detect latent tuberculosis in BCG-vaccinated children","volume":"12","author":"Chan PC","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1016\/j.vaccine.2008.08.006","article-title":"The effect of Bacille Calmette-Gu\u00e9rin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis","volume":"26","author":"Araujo Z","year":"2008","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0889-857X(05)70204-0","article-title":"Pathogenesis of rheumatoid arthritis: The role of T cells and other beasts","volume":"27","author":"Panayi GS","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1590\/1806-3713\/e20190023","article-title":"Latent tuberculosis infection in patients with rheumatic diseases","volume":"45","author":"Anton C","year":"2019","journal-title":"J Bras Pneumol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bjid.2013.05.008","article-title":"Tuberculin skin testing in inflammatory bowel disease patients from an endemic area of Brazil","volume":"18","author":"Cardoso IP","year":"2014","journal-title":"Brazilian J Infect Dis"},{"key":"ref30","first-page":"193","article-title":"Anti-TNF theraphy in Jordan: a focus on severe infections and tuberculosis","volume":"22","author":"Alawneh KM","year":"2014","journal-title":"Biologics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2334-12-199","article-title":"Influence of HTLV-1 on the clinical, microbiologic and immunologic presentation of tuberculosis","volume":"12","author":"MeL Bastos","year":"2012","journal-title":"BMC Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11904-012-0120-1","article-title":"Treatment of latent tuberculosis infection in hiv: Shorter or longer?","volume":"9","author":"Person AK","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref33","article-title":"Tuberculosis in indigenous children and adolescents in Brazil : factors associated with death and treatment dropout","volume":"35","author":"Viana PVS","year":"2019","journal-title":"Cad Sa\u00fade P\u00fablica"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.5123\/S1679-49742019000200002","article-title":"Special Tuberculosis Treatment Information System (SITE-TB) in Brazil: background, description and perspectives","volume":"28","author":"Bartholomay P","year":"2019","journal-title":"Epidemiol Serv Sa\u00fade"},{"key":"ref35","first-page":"2009","article-title":"A panorama of the health situation in Brazil\u2019s Federal District, 2005 to 2017","volume":"24","author":"Sellera PEG","year":"2019","journal-title":"Cien Saude Colet"},{"key":"ref36","article-title":"Organization of health services for tuberculosis case diagnosis and treatment in Manaus, Amazonas, Brazil, 2014","volume":"28","author":"Sacramento DS","year":"2019","journal-title":"Epidemiol Serv Sa\u00fade"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Taxa de infec\u00e7\u00e3o (tuberculose) em pacientes particulares brasileiros com DII: acompanhamento de 15 anos"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032024000100604&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T18:12:29Z","timestamp":1710526349000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032024000100604&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":36,"alternative-id":["S0004-28032024000100604"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.24612023-148","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e23148"}}